![Helmy Eltoukhy](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Helmy Eltoukhy
Amministratore Delegato presso
GUARDANT HEALTH, INC.
Patrimonio netto: 261 M $ in data 31/05/2026
Profilo
Fondatore di Guardant Health, Inc. e Avantome, Inc., Helmy Eltoukhy è attualmente amministratore delegato e direttore di Guardant Health, Inc. In precedenza ha occupato la posizione di direttore della ricerca tecnologica avanzata presso Illumina, Inc. e presidente e amministratore delegato di Avantome, Inc. (una filiale della Illumina, Inc.) e direttore dello Stanford Genome Technology Center. Il dottor Eltoukhy ha conseguito una laurea, un dottorato e una laurea presso la Stanford University.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 05/06/2026 | 2.012.919 ( 1,52% ) | 261 M $ | 31/05/2026 |
Posizioni attive di Helmy Eltoukhy
| Società | Posizione | Inizio |
|---|---|---|
| GUARDANT HEALTH, INC. | Amministratore Delegato | 01/01/2013 |
Transform Capital Management LLC
 Transform Capital Management LLC Investment ManagersFinance Transform VC invests in companies located in the United States. The firm focuses on deep tech, applied deep tech and SaaS industries. It participates in early stage transactions. | Consulente / Consigliere | - |
SETI Institute
 SETI Institute Miscellaneous Commercial ServicesCommercial Services Provides scientific research, education and public outreach studies and services | Direttore/Membro del Consiglio | - |
Green Sands Equity
 Green Sands Equity Investment ManagersFinance Green Sands Equity invests in companies located in the United States. The firm targets companies operating in the fields of technology and healthcare sectors. It provides financing for seed, early and growth stage capital requirements. | Investitore di Private Equity | - |
Precedenti posizioni note di Helmy Eltoukhy
| Società | Posizione | Fine |
|---|---|---|
| ILLUMINA, INC. | Corporate Officer/Principal | 01/12/2012 |
Avantome, Inc.
 Avantome, Inc. Medical SpecialtiesHealth Technology Provides advanced genomics services | Amministratore Delegato | 01/08/2008 |
Stanford Genome Technology Center | Corporate Officer/Principal | - |
Formazione di Helmy Eltoukhy
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
90
Relazioni di 1° grado
8
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 8 |
|---|---|
Illumina, Inc.
 Illumina, Inc. Medical SpecialtiesHealth Technology Operates as a biotechnology company that develops laboratory instruments | Health Technology |
Guardant Health, Inc.
 Guardant Health, Inc. Medical SpecialtiesHealth Technology Develops blood and tissue test devices to detect cancer & provides related screening services | Health Technology |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
SETI Institute
SETI Institute Miscellaneous Commercial ServicesCommercial Services Provides scientific research, education and public outreach studies and services | Commercial Services |
Avantome, Inc.
Avantome, Inc. Medical SpecialtiesHealth Technology Provides advanced genomics services | Health Technology |
Stanford Genome Technology Center | |
Transform Capital Management LLC
Transform Capital Management LLC Investment ManagersFinance Transform VC invests in companies located in the United States. The firm focuses on deep tech, applied deep tech and SaaS industries. It participates in early stage transactions. | Finance |
Green Sands Equity
Green Sands Equity Investment ManagersFinance Green Sands Equity invests in companies located in the United States. The firm targets companies operating in the fields of technology and healthcare sectors. It provides financing for seed, early and growth stage capital requirements. | Finance |
